Welcome to the UCL Cancer Institute
The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing better, more effective treatments to improve outcomes for cancer patients. If you are thinking about taught postgraduate study, applications to our flagship MSc Cancer programme will open in October 2016 for the academic year 2017/18.
UCL’s three biomedical research centres (BRCs) have won more than £167 million in funding from the National Institute for Health Research (NIHR) to further world-leading biomedical research conducted with partner hospitals. UCL has received more funding than any other UK university, followed by King's College London and Oxford University, which received £133m and £127m respectively.
Published: Sep 27, 2016 10:14:46 AM
For the first time, a team including UCL researchers has identified in human cancers two characteristic patterns of DNA damage caused by ionising radiation. These fingerprint patterns may now enable doctors to identify which tumours have been caused by radiation, and investigate if they should be treated differently.
Published: Sep 12, 2016 5:09:44 PM
Professor Charles Swanton has been awarded the Royal Society Napier Research Professorship in support of his exceptional work on cancer evolution and tumour genetic diversity. Professor Swanton is a world renowned expert in cancer evolution who specialises in addressing the causes and consequences of tumour evolution, with a focus on lung cancer.
Published: Sep 8, 2016 6:13:57 PM
A UCL research team led by Dr Andrew Feber is developing a blood test that could dramatically improve the way that prostate cancer is diagnosed and monitored, consequently saving thousands of men a year from undergoing painful and unnecessary biopsy tests.
Published: Sep 1, 2016 10:56:22 AM
Professor Jan Burger,MD Anderson Cancer Centre, Houston, Texas, USA, presents: BCR signaling: insight into diease biology and therapeutic targeting in Chronic Lymphocytic Leukemia (CLL), Tuesday 27th Sept, 12pm
Starts: Sep 27, 2016 12:00:00 PM
Organised by the UCL Personalised Medicine Domain, in partnership with UCL Partners the symposium will bring together around 250 group leaders and post-doctoral researchers from across UCL and Queen Mary University of London. Tuesday 8 November 2016.
Starts: Nov 8, 2016 9:00:00 AM
Support our work
Find out how you can help us to continue research that will lead to breakthroughs in cancer therapies and benefit the lives of cancer patients.